Raymond James Maintains Outperform on Insulet, Raises Price Target to $260

Benzinga · 10/14 17:15
Raymond James analyst Jayson Bedford maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $213 to $260.